课题基金 / 基金详情

A Glycobiology Facility for Glycoconjugate Analysis and Oligosaccharide Sequencing

A Glycobiology Facility for Glycoconjugate Analysis and Oligosaccharide Sequencing
用于糖复合物分析和寡糖测序的糖生物学设施
批准号:
LE0454209
负责人:
Prof Brett Garner
金额:
$8.42万
依托单位国家:
澳大利亚
项目类别:
Linkage Infrastructure, Equipment and Facilities
财政年份:
2004
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2004-03-11 至 2005-06-30

项目摘要

项目成果

Prof Brett Garner的其他基金

相似基金

相关文献

中文摘要
翻译
糖结合物的碳水化合物部分在它们的功能和代谢中起着重要作用。糖链分析和寡糖测序技术的进步为糖生物学在生物技术、细胞生物学和医学中的应用提供了巨大的潜力。这项申请旨在建立一个专门从事糖共轭分析和寡糖测序的糖生物学设施。需要资金用于在澳大利亚建立这项技术所必需的最先进的高效液相色谱设备、相关设备和葡聚糖纯化/标签试剂以及一名工作人员。该基金将支持2500万美元的现有研究;其中约一半来自ARC。
英文摘要
The carbohydrate moiety of glycoconjugates plays an important role in their function and metabolism. Advances in glycan analytical and oligosaccharide sequencing techniques offer tremendous potential for the application of glycobiology to biotechnology, cell biology and medicine. This application aims to establish a Glycobiology Facility dedicated to glycoconjugate analysis and oligosaccharide sequencing. Funds are requested for state of the art HPLC equipment, associated equipment and reagents for glycan purification/labelling, and a staff member, that are all essential to establish this technology in Australia. The Facility will support $25 million of existing research; approximately half of which is derived from ARC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Defining the mechanisms by which ABCA7 and apoE control Alzheimer's disease risk. Functional characterisation of new therapeutic targets for dementia prevention and treatment.
  • 批准号:
    nhmrc : GNT1109831
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $68.8万
  • 财政年份:
    2016
  • 负责人:
    Prof Brett Garner
  • 依托单位:
Defining the mechanisms by which ABCA7 and apoE control Alzheimer's disease risk. Functional characterisation of new therapeutic targets for dementia prevention and treatment.
  • 批准号:
    nhmrc : 1109831
  • 项目类别:
    Research Fellowships
  • 资助金额:
    $47.43万
  • 财政年份:
    2016
  • 负责人:
    Prof Brett Garner
  • 依托单位:
Lysosomal dysfunction as an inhibitor of vitamin B12 utilisation in neurodegenerative diseases
  • 批准号:
    nhmrc : 1065982
  • 项目类别:
    Project Grants
  • 资助金额:
    $37.0万
  • 财政年份:
    2014
  • 负责人:
    Prof Brett Garner
  • 依托单位:
A novel intracellular roadblock to cobalamin utilization in ageing and Alzheimer�s disease
  • 批准号:
    nhmrc : 1047848
  • 项目类别:
    NHMRC Project Grants
  • 资助金额:
    $0.75万
  • 财政年份:
    2013
  • 负责人:
    Prof Brett Garner
  • 依托单位:
海外基金